NAMS stock
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) valuation · rev $22.5M
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) rev $22.5M.
| Metric | Value |
|---|---|
| Market cap | $2.42B |
| Revenue | $22.5M |
| P/S | 107.5 |
NAMS valuation FAQ
What is NAMS's market cap?
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) market cap is $2.42B on the latest cached fundamentals snapshot.
What is NAMS's latest revenue?
Latest cached NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) revenue was $22.5M. Statements: https://lician.com/financials/nams
What is NAMS's price-to-sales ratio?
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) price-to-sales (P/S) is 107.5, cached market cap $2.42B divided by revenue $22.5M.
How many NAMS valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS): Market cap, Revenue, and P/S.
Where is NAMS valuation listed?
Cached valuation multiples for NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) are listed at https://lician.com/valuation/nams.
Not investment advice. Figures as filed or reported, not a live feed.